Skip to main content
MDXG
NASDAQ Industrial Applications And Services

FTC Second Request Delays MiMedx's $350M Sanara Acquisition

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$4.68
Mkt Cap
$682.159M
52W Low
$3.025
52W High
$7.97
52W Position info
55% above low
Off High info
41% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

MDXG sits 55% above its 52-week low of $3.025.

Summary

MiMedx disclosed that the FTC issued a Second Request on October 15, 2026, extending the HSR waiting period for its $350 million acquisition of Sanara MedTech. The deal remains subject to regulatory clearance and other closing conditions.


Key Events · M&A and Partnerships · MDXG

  • FTC Second Request Issued

    On October 15, 2026, MiMedx and Sanara each received a Second Request from the FTC for additional information and documentary materials regarding the $350 million merger.

  • HSR Waiting Period Extended

    The Second Request extends the HSR Act waiting period until 30 days after substantial compliance, unless extended voluntarily or terminated earlier by the FTC.

  • Merger Closing Conditions Remain

    Completion of the merger remains subject to expiration or termination of the HSR waiting period and satisfaction of other closing conditions.

  • Prior Shareholder Vote Scheduled

    A shareholder vote on the merger was set for September 30, 2026, as disclosed in the September 4, 2026 proxy statement.


Analysis · MDXG · Industrial Applications And Services

The FTC has issued a Second Request for additional information on MiMedx's $350 million acquisition of Sanara MedTech, extending the HSR waiting period until 30 days after substantial compliance. This new regulatory hurdle could delay or complicate the deal's closing, which was already subject to a shareholder vote on September 30. Investors should note that the merger remains pending and the Second Request introduces uncertainty around timing and potential conditions.

How filings like this one have moved

In the 30 days to Oct 16, 2026, 29.4% of the 1495 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDXG was trading at $4.68 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $682.2M. The 52-week trading range was $3.03 to $7.97. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDXG - Latest Insights

MDXG
Sep 23, 2026, 4:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $4.78
Real-time Price: $4.68 info
Change: -$0.100 (-2%) info
Market Cap: $682.159M info
MDXG
Sep 04, 2026, 4:05 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $4.55
Real-time Price: $4.68 info
Change: +$0.130 (+3%) info
Market Cap: $682.159M info
MDXG
Aug 24, 2026, 6:24 PM EDT
Filing Type: S-4
Importance Score:
8
Price at Filing: $4.33
Real-time Price: $4.68 info
Change: +$0.350 (+8%) info
Market Cap: $682.159M info
MDXG
Jul 30, 2026, 7:43 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $3.80
Real-time Price: $4.68 info
Change: +$0.880 (+23%) info
Market Cap: $682.159M info
MDXG
Jul 29, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.15
Real-time Price: $4.68 info
Change: +$0.530 (+13%) info
Market Cap: $682.159M info